Abcellera Biologics IncNASDAQ:ABCL
No Matches were found for
- LAST PRICE11.7350
- TODAY'S CHANGE (%)0.4150 (3.6661%)
- Bid / Lots11.7300/ 5
- Ask / Lots11.7400/ 2
- Open / Previous Close11.6500 / 11.3200
- Day Range
- 52 Week Range
- Volume1,956,037
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Select an index
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ABCL |
|---|---|---|
| 09:32 ET | 85316 | 11.49 |
| 09:34 ET | 26240 | 11.17 |
| 09:36 ET | 12646 | 11.13 |
| 09:38 ET | 8293 | 11.2081 |
| 09:39 ET | 11567 | 11.1912 |
| 09:41 ET | 8826 | 11.25 |
| 09:43 ET | 9645 | 11.3 |
| 09:45 ET | 7689 | 11.35 |
| 09:48 ET | 2084 | 11.32 |
| 09:50 ET | 2917 | 11.33 |
| 09:52 ET | 3546 | 11.31 |
| 09:54 ET | 7313 | 11.28 |
| 09:56 ET | 3701 | 11.285 |
| 09:57 ET | 9419 | 11.305 |
| 09:59 ET | 7034 | 11.34 |
| 10:01 ET | 6435 | 11.3 |
| 10:03 ET | 7800 | 11.2801 |
| 10:06 ET | 5874 | 11.3199 |
| 10:08 ET | 10570 | 11.34 |
| 10:10 ET | 5038 | 11.32 |
| 10:12 ET | 6638 | 11.36 |
| 10:14 ET | 3953 | 11.36 |
| 10:15 ET | 7559 | 11.34 |
| 10:17 ET | 2651 | 11.31 |
| 10:19 ET | 3827 | 11.25 |
| 10:21 ET | 13800 | 11.2736 |
| 10:24 ET | 13219 | 11.29 |
| 10:26 ET | 8293 | 11.27 |
| 10:28 ET | 6001 | 11.255 |
| 10:30 ET | 22786 | 11.22 |
| 10:32 ET | 2702 | 11.22 |
| 10:33 ET | 6478 | 11.21 |
| 10:35 ET | 10128 | 11.2 |
| 10:37 ET | 8502 | 11.195 |
| 10:39 ET | 5669 | 11.215 |
| 10:42 ET | 4513 | 11.195 |
| 10:44 ET | 7261 | 11.23 |
| 10:46 ET | 6357 | 11.235 |
| 10:48 ET | 2499 | 11.225 |
| 10:50 ET | 8252 | 11.23 |
| 10:51 ET | 1991 | 11.245 |
| 10:53 ET | 3360 | 11.27 |
| 10:55 ET | 2200 | 11.26 |
| 10:57 ET | 6287 | 11.305 |
| 11:00 ET | 8303 | 11.33 |
| 11:02 ET | 2543 | 11.335 |
| 11:04 ET | 3755 | 11.315 |
| 11:06 ET | 5198 | 11.36 |
| 11:08 ET | 3100 | 11.34 |
| 11:09 ET | 29033 | 11.27 |
| 11:11 ET | 2078 | 11.26 |
| 11:13 ET | 1730 | 11.265 |
| 11:15 ET | 3007 | 11.265 |
| 11:18 ET | 7954 | 11.255 |
| 11:20 ET | 2709 | 11.26 |
| 11:22 ET | 2278 | 11.23 |
| 11:24 ET | 8123 | 11.25 |
| 11:26 ET | 4351 | 11.27 |
| 11:27 ET | 2096 | 11.265 |
| 11:29 ET | 754 | 11.2399 |
| 11:31 ET | 1604 | 11.23 |
| 11:33 ET | 8749 | 11.25 |
| 11:36 ET | 10614 | 11.25 |
| 11:38 ET | 1181 | 11.25 |
| 11:40 ET | 19547 | 11.245 |
| 11:42 ET | 3647 | 11.25 |
| 11:44 ET | 13879 | 11.24 |
| 11:45 ET | 34387 | 11.255 |
| 11:47 ET | 5184 | 11.255 |
| 11:49 ET | 15378 | 11.2452 |
| 11:51 ET | 6244 | 11.27 |
| 11:54 ET | 1441 | 11.275 |
| 11:56 ET | 2583 | 11.265 |
| 11:58 ET | 3955 | 11.27 |
| 12:00 ET | 2100 | 11.27 |
| 12:02 ET | 3000 | 11.285 |
| 12:03 ET | 2686 | 11.26 |
| 12:05 ET | 5002 | 11.255 |
| 12:07 ET | 1731 | 11.285 |
| 12:09 ET | 1900 | 11.26 |
| 12:12 ET | 1866 | 11.28 |
| 12:14 ET | 1800 | 11.285 |
| 12:16 ET | 2391 | 11.3 |
| 12:18 ET | 4009 | 11.275 |
| 12:20 ET | 6189 | 11.27 |
| 12:21 ET | 600 | 11.255 |
| 12:23 ET | 2467 | 11.275 |
| 12:25 ET | 1738 | 11.27 |
| 12:27 ET | 10047 | 11.24 |
| 12:30 ET | 9753 | 11.245 |
| 12:32 ET | 10613 | 11.255 |
| 12:34 ET | 2254 | 11.24 |
| 12:36 ET | 3913 | 11.22 |
| 12:38 ET | 6072 | 11.2 |
| 12:39 ET | 4500 | 11.1801 |
| 12:41 ET | 3039 | 11.1623 |
| 12:43 ET | 1599 | 11.14 |
| 12:45 ET | 5692 | 11.175 |
| 12:48 ET | 6037 | 11.18 |
| 12:50 ET | 3701 | 11.215 |
| 12:52 ET | 100 | 11.2189 |
| 12:54 ET | 5957 | 11.18 |
| 12:56 ET | 2028 | 11.205 |
| 12:57 ET | 3763 | 11.175 |
| 12:59 ET | 2899 | 11.21 |
| 01:01 ET | 1984 | 11.2103 |
| 01:03 ET | 3484 | 11.185 |
| 01:06 ET | 4297 | 11.2 |
| 01:08 ET | 4000 | 11.21 |
| 01:10 ET | 4325 | 11.175 |
| 01:12 ET | 2761 | 11.16 |
| 01:14 ET | 1585 | 11.17 |
| 01:15 ET | 4862 | 11.13 |
| 01:17 ET | 1491 | 11.13 |
| 01:19 ET | 100 | 11.135 |
| 01:21 ET | 5002 | 11.125 |
| 01:24 ET | 1292 | 11.125 |
| 01:26 ET | 3284 | 11.11 |
| 01:28 ET | 689 | 11.11 |
| 01:30 ET | 2858 | 11.085 |
| 01:32 ET | 4125 | 11.12 |
| 01:33 ET | 7419 | 11.12 |
| 01:35 ET | 3453 | 11.12 |
| 01:37 ET | 1796 | 11.115 |
| 01:39 ET | 1658 | 11.12 |
| 01:42 ET | 2958 | 11.135 |
| 01:44 ET | 700 | 11.135 |
| 01:46 ET | 1100 | 11.15 |
| 01:48 ET | 1456 | 11.145 |
| 01:50 ET | 5173 | 11.145 |
| 01:51 ET | 6500 | 11.1827 |
| 01:53 ET | 1272 | 11.195 |
| 01:55 ET | 300 | 11.195 |
| 01:57 ET | 400 | 11.195 |
| 02:00 ET | 8632 | 11.24 |
| 02:02 ET | 6934 | 11.24 |
| 02:04 ET | 9945 | 11.23 |
| 02:06 ET | 21178 | 11.23 |
| 02:08 ET | 12844 | 11.255 |
| 02:09 ET | 2575 | 11.245 |
| 02:11 ET | 1820 | 11.235 |
| 02:13 ET | 3533 | 11.235 |
| 02:15 ET | 23326 | 11.2691 |
| 02:18 ET | 130473 | 11.3 |
| 02:20 ET | 36806 | 11.355 |
| 02:22 ET | 68745 | 11.569 |
| 02:24 ET | 31641 | 11.56 |
| 02:26 ET | 21263 | 11.58 |
| 02:27 ET | 33158 | 11.5712 |
| 02:29 ET | 13192 | 11.5979 |
| 02:31 ET | 37792 | 11.64 |
| 02:33 ET | 10584 | 11.5993 |
| 02:36 ET | 11449 | 11.6116 |
| 02:38 ET | 19059 | 11.63 |
| 02:40 ET | 11546 | 11.65 |
| 02:42 ET | 8527 | 11.67 |
| 02:44 ET | 10681 | 11.68 |
| 02:45 ET | 21633 | 11.65 |
| 02:47 ET | 12306 | 11.7075 |
| 02:49 ET | 15958 | 11.6998 |
| 02:51 ET | 9236 | 11.67 |
| 02:54 ET | 7274 | 11.65 |
| 02:56 ET | 13857 | 11.69 |
| 02:58 ET | 30526 | 11.75 |
| 03:00 ET | 27552 | 11.748 |
| 03:02 ET | 12780 | 11.67 |
| 03:03 ET | 14344 | 11.6792 |
| 03:05 ET | 19738 | 11.705 |
| 03:07 ET | 7327 | 11.715 |
| 03:09 ET | 21908 | 11.75 |
| 03:12 ET | 8178 | 11.71 |
| 03:14 ET | 9318 | 11.72 |
| 03:16 ET | 12793 | 11.72 |
| 03:18 ET | 38491 | 11.775 |
| 03:20 ET | 4113 | 11.735 |
Aug 3, 2022
AbCellera Biologics, Atlas Venture Enter Partnership to Develop Target-specific Antibodies, from 3:14PM ET on Wednesday Aug 03, 2022 by MT Newswires
3:14PM ET on Wednesday Aug 03, 2022 by MT NewswiresBRIEF-Abcellera And Atlas Venture Collaborate To Empower The Development Of Impactful Medicines For Patients, from 7:13AM ET on Wednesday Aug 03, 2022 by Thomson Reuters
7:13AM ET on Wednesday Aug 03, 2022 by Thomson ReutersAbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients, from 7:00AM ET on Wednesday Aug 03, 2022 by Business Wire
7:00AM ET on Wednesday Aug 03, 2022 by Business Wire
Jul 27, 2022
AbCellera Biologics, Versant Ventures to Collaborate on Therapeutic Antibodies, from 10:06AM ET on Wednesday Jul 27, 2022 by MT Newswires
10:06AM ET on Wednesday Jul 27, 2022 by MT NewswiresBRIEF-Versant Ventures Collaborates With Abcellera , from 7:51AM ET on Wednesday Jul 27, 2022 by Thomson Reuters
7:51AM ET on Wednesday Jul 27, 2022 by Thomson Reuters
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Abcellera Biologics Inc | 3.2B | 18.0x | --- |
Amicus Therapeutics Inc | 3.4B | -12.8x | --- |
Insmed Inc | 3.3B | -8.0x | --- |
Ultragenyx Pharmaceutical Inc | 3.9B | -7.2x | --- |
Genmab A/S | 23.1B | 71.1x | --- |
ACADIA Pharmaceuticals Inc | 2.7B | -12.5x | --- |
Company Information
AbCellera Biologics Inc. (AbCellera) is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning, and hyper-scale data science. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, enabling them to tackle the toughest problems in drug development.
Contact Information
- Headquarters
- 2215 Yukon StreetVANCOUVER, BC, Canada V5Y 0A1
- Phone
- 604-559-9005
- Fax
- ---
Executives
- Chairman of the Board, President, Chief Executive Officer, Co-Founder
- Carl Hansen
- Co-Founder, Chief Operating Officer, Director
- Veronique Lecault
- Chief Financial Officer
- Andrew Booth
- Chief Compliance Officer, Corporate Secretary, Chief Legal Officer
- Tryn Stimart
- Chief Commercial Officer
- Neil Aubuchon
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
|---|---|
Revenue (TTM) | $489.1M |
Shares Outstanding | 284.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $0.65 |
Book Value | $3.62 |
P/E Ratio | 18.0x |
Price/Sales (TTM) | 6.6 |
Price/Cash Flow (TTM) | 14.6x |
Operating Margin | 55.49% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
